Mustang Bio Inc
MBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.08M
Close$
$0.35
52.5% downside
Current Fair Value
52.5% downsideOvervalued by 52.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.08 Million |
|---|---|
| Enterprise Value | $-11,030,315.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.39 |
| Beta | 2.11 |
| Outstanding Shares | 6,729,855 |
Return
| Return on Equity | -31.68% |
|---|---|
| Return on Assets | -16.42% |
| Return on Invested Capital | -35.23% |
Valuation & Multiples
| P/E Ratio | -1.66 |
|---|---|
| PEG | -0.32 |
| Price to Sales | - |
| Price to Book Ratio | 0.74 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 3.58 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 18, 2026
EPS Estimate
$-145.50
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.04%▼ 7.81% |
|---|---|
| Total Invested | $369,848▼ 31.75% |
| Investors Holding | 22▼ 2.00% |
ESG Score
No data